Gorelick Is a New Senior VP at PharmaPrint
Kenneth J. Gorelick has been appointed senior vice president of drug development and chief medical officer for PharmaPrint Inc., an Irvine manufacturer of herbal supplements and pharmaceuticals. Gorelick recently served as vice president, product planning and acquisition, and vice president, clinical research and development for Dupont Merck Pharmaceutical Co.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
